Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 10673 - 10680 of 11616 results
Five Years in the Making - IRS Releases Findings from Colleges and Universities Compliance Project
May 13, 2013| Blog| Viewpoint
EU Data Protection Regulation: and the horizon recedes again . . .
May 10, 2013| Blog| Viewpoint
Five Takeaways from the OIG’s Special Advisory Bulletin on Exclusion
May 10, 2013| Advisory| Viewpoint
How to Minimize FCPA Risk in Health Care Acquisitions
May 10, 2013| Blog| Viewpoint
Final Medical Marijuana Regulations Approved in Massachusetts
May 10, 2013| Blog| Viewpoint
CBP Begins Rollout of Automated Form I-94 Arrival/Departure Record for Travelers Arriving by Air or Sea
May 3, 2013| Alert| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.